Survival After Pancreaticoduodenectomy is not Improved by Extending Resections to Achieve Negative Margins

被引:105
作者
Hernandez, Jonathan [1 ]
Mullinax, John [1 ]
Clark, Whalen [1 ]
Toomey, Paul [1 ]
Villadolid, Desiree [1 ]
Morton, Connor [1 ]
Ross, Sharona [1 ]
Rosemurgy, Alexander [1 ]
机构
[1] Univ S Florida, Dept Surg, Tampa Gen Hosp, Ctr Digest Disorders, Tampa, FL 33601 USA
关键词
LONG-TERM SURVIVAL; DUCTAL ADENOCARCINOMA; PANCREATIC-CANCER; PROGNOSTIC INDICATORS; 5-YEAR SURVIVORS; LYMPHADENECTOMY; HEAD; STANDARD; SURGERY; TRIAL;
D O I
10.1097/SLA.0b013e3181ad655e
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: This study was undertaken to determine the survival benefit of extending resections to obtain microscopically negative margins after positive intraoperative frozen sections. Summary Background Data: The impact of residual microscopic disease after pancreaticoduodenectomy is currently a point of controversy. It is, however, generally believed that microscopically positive margins negatively impact survival and this may be improved by ultimately achieving negative margins. Methods: Since 1995, patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma have been prospectively followed. Margin status has been codified as macro/microscopically negative (R0) or macroscopically negative/microscopically positive (R1). The impact of margin status on survival was evaluated utilizing Survival curve analysis. Data are presented as median, mean +/- SD where appropriate. Results: For pancreatic adenocarcinoma, 202 patients underwent pancreaticoduodenectomy. R0 resections were achieved in 158 patients, 17 of whom required extended resections to achieve complete tumor extirpation after an initially positive intraoperative frozen section (R1 -> R0). R1 resections were undertaken in 44 patients. Median survival for patients undergoing R0 resections was 21 months, 26 +/- 23.4 months versus 13 months, 17 +/- 21.0 months for patients undergoing RI resections (P = 0.02). Median survival for patients undergoing R1 -> R0 resections was 11 months, 16 +/- 17.3, (P = 0.001). Margin status had a significant correlation with "N" stage and AJCC stage but not "T" stage. Conclusion: Survival after pancreaticoduodenectomy is not improved by extending pancreatic resections to achieve negative margins after initially positive intraoperative frozen sections. Tumor-specific factors beyond the presence of disease at a surgical margin are responsible for the abbreviated survival seen in patients undergoing RI resections.
引用
收藏
页码:76 / 80
页数:5
相关论文
共 19 条
[1]   Current standards of surgery for pancreatic cancer [J].
Alexakis, N ;
Halloran, C ;
Raraty, M ;
Ghaneh, P ;
Sutton, R ;
Neoptolemos, JP .
BRITISH JOURNAL OF SURGERY, 2004, 91 (11) :1410-1427
[2]   Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration [J].
Breslin, TM ;
Hess, KR ;
Harbison, DB ;
Jean, ME ;
Cleary, KR ;
Dackiw, AP ;
Wolff, RA ;
Abbruzzese, JL ;
Janjan, NA ;
Crane, CIH ;
Vauthey, JN ;
Lee, JE ;
Pisters, PWT ;
Evans, DB .
ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (02) :123-132
[3]   Influence of resection margins and treatment on survival in patients with pancreatic cancer -: Meta-analysis of randomized controlled trials [J].
Butturini, Giovanni ;
Stocken, Deborah D. ;
Wente, Moritz N. ;
Jeekel, Hans ;
Klinkenbijl, Johaness H. G. ;
Bakkevold, Kare E. ;
Takada, Tadahiro ;
Amano, Hirano ;
Dervenis, Christos ;
Bassi, Claudio ;
Buechler, Markus W. ;
Neoptolemos, John P. .
ARCHIVES OF SURGERY, 2008, 143 (01) :75-83
[4]   Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-year survivors [J].
Cleary, SP ;
Gryfe, R ;
Guindi, M ;
Greig, P ;
Smith, L ;
Mackenzie, R ;
Strasberg, S ;
Hanna, S ;
Taylor, B ;
Langer, B ;
Gallinger, S .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 198 (05) :722-731
[5]   Long-term survival after curative resection for pancreatic ductal adenocarcinoma - Clinicopathologic analysis of 5-year survivors [J].
Conlon, KC ;
Klimstra, DS ;
Brennan, MF .
ANNALS OF SURGERY, 1996, 223 (03) :273-279
[6]   A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma [J].
Farnell, MB ;
Pearson, RK ;
Sarr, MG ;
DiMagno, EP ;
Burgart, LJ ;
Dahl, TR ;
Foster, N ;
Sargent, DJ .
SURGERY, 2005, 138 (04) :618-628
[7]   PROGNOSTIC INDICATORS FOR SURVIVAL AFTER RESECTION OF PANCREATIC ADENOCARCINOMA [J].
GEER, RJ ;
BRENNAN, MF .
AMERICAN JOURNAL OF SURGERY, 1993, 165 (01) :68-72
[8]   Surgery for ductal adenocarcinoma of the pancreatic head:: Staging, complications, and survival after regional versus extended lymphadenectomy [J].
Henne-Bruns, D ;
Vogel, I ;
Lüttges, J ;
Klöppel, G ;
Kremer, B .
WORLD JOURNAL OF SURGERY, 2000, 24 (05) :595-602
[9]   The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas [J].
Lüttges, J ;
Vogel, I ;
Menke, M ;
Henne-Bruns, D ;
Kremer, B ;
Klöppel, G .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1998, 433 (03) :237-242
[10]   Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial [J].
Neoptolemos, JP ;
Stocken, DD ;
Dunn, JA ;
Almond, J ;
Beger, HG ;
Pederzoli, P ;
Bassi, C ;
Dervenis, C ;
Fernandez-Cruz, L ;
Lacaine, F ;
Buckels, J ;
Deakin, M ;
Adab, FA ;
Sutton, R ;
Imrie, C ;
Ihse, I ;
Tihanyi, T ;
Olah, A ;
Pedrazzoli, S ;
Spooner, D ;
Kerr, DJ ;
Friess, H ;
Büchler, MW .
ANNALS OF SURGERY, 2001, 234 (06) :758-768